Bristol Myers Squibb (BMY)

EBITDA Growth

11.59%

TTM · Period ending:

BMY logo

BMY EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported11.59%
BMY TTM EBITDA YoY % (20.65% → 11.59%)
High-resolution chart · PNG

BMY ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bristol Myers Squibb EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
11.5859%
-7.4426%
380.7449%
193.8671%
192.6214%
204.5865%
-83.6414%
-74.1091%
-74.0292%
-73.5468%
0.7544%
1.4451%
2.0955%
4.9416%
-4.4587%
142.7943%
142.8482%
141.2083%
308.1558%
-42.045%
-21.5267%
2.9412%
-33.1842%
77.8253%
21.8701%
10.0371%
8.6771%
28.4074%
65.5384%
19.063%
10.9876%
-6.3727%
-24.6532%
-14.5489%
-5.3837%
30.3147%
54.0671%
146.4784%
145.127%
62.8638%
42.1758%
-19.5802%
-13.5693%
-25.4805%
-22.1516%
-15.0049%
-20.8149%
15.5138%
170.6125%
111.8012%
20.2935%
-17.9781%
-79.9724%
-75.9552%
-59.0147%
-43.8295%
-3.1246%
10.4316%
12.2845%
20.2302%
18.5907%
16.5839%
16.3296%
-11.6098%
-6.8584%
-4.3818%
-9.9488%
35.6589%
36.0899%
43.3245%
65.1093%
46.8351%
55.7362%
33.7052%
13.416%
-13.6832%
-31.6745%
-28.5804%
-27.2951%
-17.2844%
-10.9547%
-9.3863%
-8.9042%
-8.6713%
-7.7544%
-8.9131%
-6.6237%
2.3342%
12.3153%
23.6729%
14.0557%
-4.9146%
-16.2956%
-30.1017%
-26.1814%
-17.6172%
-12.8378%
-4.3229%
-1.3607%
0.6573%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.